Filing Details
- Accession Number:
- 0001209191-21-017536
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-03 20:36:52
- Reporting Period:
- 2021-03-01
- Accepted Time:
- 2021-03-03 20:36:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1754068 | Allovir Inc. | ALVR | Biological Products, (No Disgnostic Substances) (2836) | 831971007 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1755495 | Juan Vera | C/O Allovir, Inc. 139 Main Street, Suite 500 Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-03-01 | 11,570 | $38.28 | 2,392,194 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-01 | 20,584 | $38.73 | 2,371,610 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-01 | 700 | $39.53 | 2,370,910 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-02 | 4,190 | $37.28 | 2,366,720 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-02 | 9,001 | $38.30 | 2,357,719 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-02 | 1,803 | $39.10 | 2,355,916 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-03 | 1,300 | $37.01 | 2,354,616 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-03 | 7,142 | $38.22 | 2,347,474 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-03 | 7,546 | $38.63 | 2,339,928 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.49 to $38.48. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.49 to $39.478. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.515 to $39.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.84 to $37.83. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.84 to $38.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.84 to $39.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.50 to $37.44. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.50 to $38.495. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.50 to $38.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.